Malignant neoplasm of unspecified ovary
ICD-10 C56.9 is a billable code used to indicate a diagnosis of malignant neoplasm of unspecified ovary.
C56.9 refers to a malignant neoplasm of the ovary where the specific site is not identified. Ovarian cancer is a significant gynecologic malignancy, often diagnosed at an advanced stage due to vague symptoms. The neoplasm can arise from various cell types, including epithelial, germ cell, and stromal cells. Symptoms may include abdominal bloating, pelvic pain, and changes in urinary habits. Diagnosis typically involves imaging studies, such as ultrasound or CT scans, and tumor markers like CA-125, which can aid in monitoring treatment response and disease progression. Staging of ovarian cancer is crucial for treatment planning and is based on the FIGO system, which considers tumor size, spread to lymph nodes, and distant metastasis. Treatment often involves a combination of surgery and chemotherapy, with surgical approaches including total abdominal hysterectomy and bilateral salpingo-oophorectomy, depending on the extent of the disease.
Detailed pathology reports, imaging studies, and treatment plans.
Diagnosis and treatment planning for ovarian cancer, monitoring treatment response.
Ensure accurate staging and documentation of tumor markers.
Surgical notes, pre-operative assessments, and post-operative follow-ups.
Surgical intervention for ovarian masses, management of ovarian cancer.
Document the extent of disease and any findings during surgery.
Performed for malignant neoplasm of the ovary.
Operative report detailing the procedure and findings.
Oncology and gynecology must coordinate on staging and treatment.
C56.9 represents a malignant neoplasm of the ovary where the specific site is not specified, requiring careful documentation to support the diagnosis.
